Urgent Call for Volunteers: Bath Hospital Explores Breakthrough Stroke Drug

The Royal United Hospitals (RUH) Bath NHS Foundation Trust is embarking on an exciting research study aimed at reducing the risk of recurrent strokes with a promising new anticoagulant medication known as Milvexian. This groundbreaking study, named the Librexia study, seeks to determine whether this innovative drug can effectively cut down the incidence of future ischaemic strokes among patients who have recently experienced a stroke or transient ischaemic attack.

Eligibility for Participation

To participate in this critical trial, volunteers must be aged 40 or older and have visited RUH within 48 hours following an ischaemic stroke or transient ischaemic attack. The outcomes of this study could be life-changing, as ischaemic strokes arise when a blockage interrupts the blood supply to the brain, leading to severe consequences such as speech difficulties, visual impairments, and weakness in limbs.

Expert Insights

Kelly Spencer, head of research operations at RUH, emphasized the study's potential impact, describing it as capable of producing a “really positive outcome.” She expressed her enthusiasm about the hospital’s involvement in such a pivotal medical trial, reinforcing RUH's reputation for excellence in clinical research.

About Milvexian Treatment

The unique mechanism of Milvexian works by thinning the blood, which may help prevent the formation of harmful blood clots. Participants in the study will be randomly assigned to receive either the Milvexian treatment or a placebo, combined with the standard care prescribed by their healthcare provider. Each participant will then attend follow-up appointments at RUH every 13 weeks for evaluations that include blood tests and assessments of liver and kidney function.

Call to Action

This research is not only crucial for the individuals involved but could herald a new era in stroke prevention and treatment, offering hope to countless others at risk. As residents of Bath and beyond are urged to consider volunteering for this important study, we are reminded of the vital role such trials play in advancing medical science and improving patient care.

Get Involved

If you or someone you know meets the criteria, this could be an opportunity to contribute to groundbreaking research that may save lives. Don’t miss the chance to make a difference!